Bendamustine in patients with rituximab-refractory indolent and transformed non-hodgkin's lymphoma: Results from a phase II multicenter, single-agent study (vol 26, pg 204, 2008)

被引:8
作者
Friedberg
机构
关键词
D O I
10.1200/JCO.2008.16.8013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1911 / 1911
页数:1
相关论文
共 1 条
[1]   Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: Results from a phase II multicenter, single-agent study [J].
Friedberg, Jonathan W. ;
Cohen, Philip ;
Chen, Ling ;
Robinson, K. Sue ;
Forero-Torres, Andres ;
La Casce, Ann S. ;
Fayad, Luis E. ;
Bessudo, Alberto ;
Camacho, Elber S. ;
Williams, Michael E. ;
Van der Jagt, Richard H. ;
Oliver, Jennifer W. ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) :204-210